Calcium gluconate - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for calcium gluconate and what is the scope of patent protection?
Calcium gluconate
is the generic ingredient in two branded drugs marketed by Amneal, B Braun Medical Inc, Fresenius Kabi Usa, Nivagen Pharms Inc, Somerset, and Hq Spclt Pharma, and is included in seven NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for calcium gluconate. Eleven suppliers are listed for this compound.
Summary for calcium gluconate
US Patents: | 2 |
Tradenames: | 2 |
Applicants: | 6 |
NDAs: | 7 |
Drug Master File Entries: | 4 |
Finished Product Suppliers / Packagers: | 11 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 30 |
Patent Applications: | 6,514 |
Drug Prices: | Drug price trends for calcium gluconate |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for calcium gluconate |
What excipients (inactive ingredients) are in calcium gluconate? | calcium gluconate excipients list |
DailyMed Link: | calcium gluconate at DailyMed |
Recent Clinical Trials for calcium gluconate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ascension Genesys Hospital | Phase 2 |
Aurora Health Care | Phase 4 |
First Affiliated Hospital Xi'an Jiaotong University | N/A |
Pharmacology for calcium gluconate
Drug Class | Blood Coagulation Factor Phosphate Binder |
Mechanism of Action | Phosphate Chelating Activity |
Physiological Effect | Increased Coagulation Factor Activity |
Anatomical Therapeutic Chemical (ATC) Classes for calcium gluconate
US Patents and Regulatory Information for calcium gluconate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amneal | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 217174-001 | Sep 5, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Fresenius Kabi Usa | CALCIUM GLUCONATE IN SODIUM CHLORIDE | calcium gluconate | SOLUTION;INTRAVENOUS | 208418-004 | Jun 17, 2021 | AP | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
Somerset | CALCIUM GLUCONATE | calcium gluconate | SOLUTION;INTRAVENOUS | 217689-001 | Oct 19, 2023 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.